| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2b46e05f9bbd846aa4d07ff31a59d82 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate |
2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_558b1e8e740b8695130c788229a32307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f94ec89732be1c8d678f6c7c6e7d277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21d0db305d40175ae7b46c981bb6381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941a7f6c272a3a3a57e1f2addf470afd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c4a772b8c7843a9a4c4da47cc14b641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2408aeb6045813e7242056e9dca03f3 |
| publicationDate |
2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013116217-A1 |
| titleOfInvention |
Neuroprotection and myelin repair using nestorone® |
| abstract |
Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17α-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration, and include effects on stroke and TBI. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016209847-A1 |
| priorityDate |
2009-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |